SEC Form 4 · accession 0001493152-26-036080
Inhibitor Therapeutics, Inc. · INTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jul 1, 2026
Accepted (ET)
Aug 4, 2026 · 9:03 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001042418
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 1, 2026 | G | 3,200,000 | $0.00 | D | 19,901,057 | D |
Table II — derivative securities
No Table II lines on this filing.